INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

Boca Raton, Florida, October 14th, 2026, Financewire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro. Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development.

Covered by 2 publishers within 6 hours of the first report.

Summary from The Next Web.

Reporting2

TNW The Next Web INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro · Technology Newswire 8:45 AM

HPC HPCwire INmune Bio and QCi Combine Quantum Computing and AI to Study Drug Applications · Andrew Jolly 2:38 PM

Related

HPC Fujitsu partners with New Mexico on quantum computing research center October 8

QZ Nvidia pledges $1 billion to support U.S. scientific research October 8

FC DARPA just picked four early winners for its quantum initiative October 7

DCD D-Wave extends chip manufacturing partnership with SkyWater October 13

Topics Quantum computing